Trv Gp Iii, LLC Pliant Therapeutics, Inc. Transaction History
Trv Gp Iii, LLC
- $6.14 Million
- Q4 2023
A detailed history of Trv Gp Iii, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Trv Gp Iii, LLC holds 339,160 shares of PLRX stock, worth $481,607. This represents 100.0% of its overall portfolio holdings.
Number of Shares
339,160
Previous 339,160
-0.0%
Holding current value
$481,607
Previous $5.88 Million
4.44%
% of portfolio
100.0%
Previous 100.0%
Shares
4 transactions
Others Institutions Holding PLRX
# of Institutions
172Shares Held
64.7MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$8.48 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.06 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$6.58 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$4.58 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$4.54 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $69.1M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...